2024
DOI: 10.3390/jcdd11010029
|View full text |Cite
|
Sign up to set email alerts
|

Developments and Challenges in Durable Ventricular Assist Device Technology: A Comprehensive Review with a Focus on Advancements in China

Jingrong Tu,
Li Xu,
Fei Li
et al.

Abstract: Heart transplantation is currently the most effective treatment for end-stage heart failure; however, the shortage in donor hearts constrains the undertaking of transplantation. Mechanical circulatory support (MCS) technology has made rapid progress in recent years, providing diverse therapeutic options and alleviating the dilemma of donor heart shortage. The ventricular assist device (VAD), as an important category of MCS, demonstrates promising applications in bridging heart transplantation, destination ther… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 76 publications
0
2
0
Order By: Relevance
“…HeartMate III, with FullMagLev technology, stands out for its durability and reduced complications. MOMENTUM 3 study confirms its superiority in patient outcomes, underscoring the continual evolution of VAD technology (Tu et al, 2024).…”
Section: Future Advancements and Durability Of Ventricular Assist Devicementioning
confidence: 76%
See 1 more Smart Citation
“…HeartMate III, with FullMagLev technology, stands out for its durability and reduced complications. MOMENTUM 3 study confirms its superiority in patient outcomes, underscoring the continual evolution of VAD technology (Tu et al, 2024).…”
Section: Future Advancements and Durability Of Ventricular Assist Devicementioning
confidence: 76%
“…Future work might focus on reducing blood clot risk and improving impeller designs where blood can flow effectively without further consequences. Latest technology is still working on adjusting pump flow and using AI for real-time optimization (Tu et al, 2024). This research noted viable evolution in durable ventricular assist device (dVAD) use with a surge in implantations coinciding with severe HF patient profiles, favoring destination therapy over bridge to transplant which has become possible with invent of dVAD technology (Tu et al, 2024).…”
Section: Future Advancements and Durability Of Ventricular Assist Devicementioning
confidence: 99%